AKYA vs NOTV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKYA is a Hold and NOTV is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AKYA’s FA Score shows that 0 FA rating(s) are green whileNOTV’s FA Score has 0 green FA rating(s).
- AKYA’s FA Score: 0 green, 5 red.
- NOTV’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AKYA’s TA Score shows that 4 TA indicator(s) are bullish while NOTV’s TA Score has 3 bullish TA indicator(s).
- AKYA’s TA Score: 4 bullish, 5 bearish.
- NOTV’s TA Score: 3 bullish, 4 bearish.
Price Growth
AKYA (@Medical Specialties) experienced а -32.27% price change this week, while NOTV (@Medical Specialties) price change was +24.91% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +3.14%. For the same industry, the average monthly price growth was +0.91%, and the average quarterly price growth was -2.33%.
Reported Earning Dates
AKYA is expected to report earnings on Mar 10, 2025.
NOTV is expected to report earnings on Feb 13, 2025.
Industries' Descriptions
@Medical Specialties (+3.14% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| AKYA | NOTV | AKYA / NOTV | |
| Capitalization | 230M | 255M | 90% |
| EBITDA | -45.63M | 59M | -77% |
| Gain YTD | -56.557 | -7.084 | 798% |
| P/E Ratio | N/A | 169.49 | - |
| Revenue | 96.6M | 585M | 17% |
| Total Cash | 83.1M | 22M | 378% |
| Total Debt | 85.7M | 429M | 20% |
NOTV | ||
|---|---|---|
OUTLOOK RATING 1..100 | 24 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 97 | |
PRICE GROWTH RATING 1..100 | 35 | |
P/E GROWTH RATING 1..100 | 82 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AKYA | NOTV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 88% | 2 days ago 87% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 89% |
| Advances ODDS (%) | 17 days ago 78% | 2 days ago 89% |
| Declines ODDS (%) | 5 days ago 89% | 8 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 83% |
| Aroon ODDS (%) | N/A | N/A |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LVOOX | 23.00 | 0.40 | +1.77% |
| Lord Abbett Value Opportunities F3 | |||
| JFNAX | 73.43 | 0.22 | +0.30% |
| Janus Henderson Global Life Sciences A | |||
| ALGAX | 19.76 | N/A | N/A |
| Alger International Opportunities A | |||
| SWLSX | 35.46 | N/A | N/A |
| Schwab Large-Cap Growth | |||
| MSDUX | 13.36 | -0.02 | -0.15% |
| Morgan Stanley Emerging Mkt ex China I | |||
AKYA and
Correlation & Price change
A.I.dvisor indicates that over the last year, AKYA has been loosely correlated with MXCT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AKYA jumps, then MXCT could also see price increases.
| Ticker / NAME | Correlation To AKYA | 1D Price Change % | ||
|---|---|---|---|---|
| AKYA | 100% | -1.85% | ||
| MXCT - AKYA | 36% Loosely correlated | -1.15% | ||
| NOTV - AKYA | 34% Loosely correlated | +6.23% | ||
| IRMD - AKYA | 34% Loosely correlated | +2.21% | ||
| ICUI - AKYA | 32% Poorly correlated | +0.75% | ||
| FLGT - AKYA | 32% Poorly correlated | -1.91% | ||
More | ||||
NOTV and
Correlation & Price change
A.I.dvisor indicates that over the last year, NOTV has been loosely correlated with RGEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NOTV jumps, then RGEN could also see price increases.
| Ticker / NAME | Correlation To NOTV | 1D Price Change % | ||
|---|---|---|---|---|
| NOTV | 100% | +6.23% | ||
| RGEN - NOTV | 36% Loosely correlated | +2.06% | ||
| AKYA - NOTV | 34% Loosely correlated | -1.85% | ||
| CRL - NOTV | 32% Poorly correlated | +3.35% | ||
| CDNA - NOTV | 28% Poorly correlated | +0.94% | ||
| BVS - NOTV | 28% Poorly correlated | +0.88% | ||
More | ||||